- Report
- July 2024
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- December 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- December 2024
- 387 Pages
Global
From €3990EUR$4,197USD£3,352GBP
- Report
- December 2024
- 427 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- October 2024
- 191 Pages
Global
From €2329EUR$2,450USD£1,957GBP
- Report
- September 2024
- 154 Pages
Global
From €2139EUR$2,250USD£1,797GBP
- Report
- March 2025
- 194 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 182 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 189 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 187 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 197 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 150 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- July 2024
- 142 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- March 2025
- 383 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 289 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 193 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- February 2025
- 369 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- February 2025
- 202 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- August 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- June 2024
- 309 Pages
Global
From €3327EUR$3,500USD£2,795GBP
€4753EUR$5,000USD£3,993GBP

The Adult Stem Cell market is a subset of the larger Stem Cell market, which is focused on the use of stem cells for medical treatments. Adult stem cells are found in the body and are used to replace or repair damaged tissue. These cells can be harvested from a patient's own body, or from a donor, and then used to treat a variety of conditions, including cancer, heart disease, and neurological disorders.
The Adult Stem Cell market is driven by the increasing demand for stem cell therapies, as well as the development of new technologies and techniques for harvesting and processing stem cells. Additionally, the market is supported by government funding and private investments.
Companies in the Adult Stem Cell market include Celgene Corporation, Osiris Therapeutics, Inc., Athersys, Inc., and Mesoblast Limited. Show Less Read more